Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the pharmacology and safety of topical finasteride for treating androgenetic alopecia and female pattern hair loss, noting positive results but reporting no new clinical findings.

This study found that 65.2% of female pattern hair loss patients showed significant hair growth improvement with a daily dosage of 2.5 mg finasteride, with better outcomes in patients with lower initial Ludwig scores and older age at onset.

This study concluded that there is no association between male pattern baldness and the severity or presence of coronary artery disease as measured by Gensini and Rentrop scores.

This perspective highlights the role of inflammation in male and female pattern hair loss and its implications for developing future therapeutic options.

In this report, five female patients undergoing hormonal anticancer therapy for breast cancer prevention developed pattern alopecia, which the authors attribute to androgen-estrogen imbalance caused by antiestrogenic drugs.

This study found that t-flavanone may promote hair growth in people with androgenic alopecia by enhancing hair anchoring strength and upregulating desmoglein expression in hair follicles over 30 weeks.

This study found that specific CYP19A1 gene SNPs were significantly associated with female pattern hair loss risk in a Chinese Han population.

PRP treatment satisfies 58% of female hair loss patients, with most noticing fuller, thicker hair and less shedding.

This study found that Chinese patients with alopecia areata, female pattern hair loss, and male androgenetic alopecia had significantly lower serum vitamin D levels than healthy individuals.

This study found that male pattern hair loss worsened significantly after stopping finasteride, revealing a "rebound effect" where terminal hair transformed into miniaturized hair over 30 months off the drug.

This case report details a woman with autoimmune primary ovarian insufficiency linked to hormonal contraception discontinuation, who achieved pregnancy through ovarian stimulation and in vitro fertilization despite typically low fertility in such conditions.

Follicular unit transplantation treats hair loss and restores eyebrows with short recovery and natural results.

This study found that several factors, including ponytail hairstyles and alcohol consumption, were associated with increased severity of female pattern hair loss in the surveyed Chinese women.

This study found that the washing method can help differentiate chronic telogen effluvium from mild female pattern hair loss, potentially reducing the need for biopsies.

This article discusses the causes, characteristics, and management of female-pattern hair loss without reporting new clinical results and emphasizes the need for treatment to prevent further hair density decline.

In this case report, two young women with female pattern hair loss experienced significant hair regrowth without adverse effects after six months of treatment with bone-marrow-derived mesenchymal stem cells and their extracellular vesicles, suggesting potential for this approach when conventional treatments fail.

This case report suggests that a classical homeopathic approach at Dr Batra’s® Homeopathy Clinic significantly improved hair fall, hair density, and quality of life for a young male with Grade III Male Pattern Baldness over 18 months.

Certain combination therapies, like microneedling with minoxidil, are more effective for female-pattern hair loss than other treatments.

In this study, PRP treatment improved hair loss in 40 female patients with female pattern alopecia, with most progressing to better grades of hair coverage after 6 months, while only minor pain was occasionally reported as an adverse effect.

This article revisits the genetics of pattern baldness but reports no new clinical findings.

This abstract discusses the potential of platelet-rich plasma as a promising solution for hair loss and thinning, highlighting its efficiency, safety, and reproducibility compared to traditional treatments like hair grafts.

In this study of women treated for dermatological conditions in West Midlands, England, low vitamin D levels were significantly linked to hair loss, especially in women aged 35-45, suggesting vitamin D's potential role in prevention and treatment of hair loss in this group.

The abstract discusses the potential of platelet-rich plasma as a new, efficient, safe, and reproducible solution for hair loss and thinning, highlighting advancements in growth factors and stem cell technology. However, this summary does not report specific findings or results.

This article discusses female pattern baldness and effective treatments like oral anti-androgens and topical minoxidil for managing its progression and reversing hair follicle shrinkage, but reports no new findings.

Two treatments for male pattern hair loss are minoxidil and finasteride, but they have side effects and may not satisfy everyone.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

This study concluded that horizontal sections of scalp biopsy specimens provide more diagnostic information for male pattern androgenetic alopecia than vertical sections and can predict hair regrowth potential following topical minoxidil therapy.

In this 48-week trial, 5% topical minoxidil was more effective than both 2% minoxidil and placebo in promoting hair growth in women with female pattern hair loss, with notable improvements in nonvellus hair count and hair growth assessments.

This article reviews the historical developments in understanding and treating male pattern hair loss, emphasizing the role of dihydrotestosterone and 5α-reductase inhibitors, but reports no new clinical findings.

Minoxidil promotes hair growth in male pattern baldness.